|
Business combinations (Details Textual) (USD $)
In Millions, unless otherwise specified |
9 Months Ended | 3 Months Ended | 1 Months Ended | 3 Months Ended | ||||
|---|---|---|---|---|---|---|---|---|
|
Sep. 30, 2012
|
Sep. 30, 2012
Micromet, Inc. [Member]
|
Jun. 30, 2012
Micromet, Inc. [Member]
|
Mar. 07, 2012
Micromet, Inc. [Member]
|
Mar. 07, 2012
Micromet, Inc. [Member]
Developed technology [Member]
|
Jun. 12, 2012
Mustafa Nevzat Pharmaceuticals [Member]
|
Sep. 30, 2012
Mustafa Nevzat Pharmaceuticals [Member]
|
Jul. 05, 2012
KAI Pharmaceuticals [Member]
|
|
| Business Combinations (Textual) [Abstract] | ||||||||
| Percentage of equity interest in acquisition | 99.40% | |||||||
| Total consideration | $ 1,146 | $ 677 | $ 332 | |||||
| Impairment charge | 19 | |||||||
| Finite-lived intangible assets, estimated useful life (in years) | 10 years | 8 years | ||||||
| Goodwill | 330 | 382 | 146 | |||||
| Goodwill, translation adjustments | (19) | |||||||
| Goodwill, other increases (decreases) | (38) | 12 | ||||||
| Deferred tax assets | $ 43 | |||||||